£7m invested in fight against antimicrobial resistance
Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has announced £7m in new investment.
The financing was led by growth...
CRYONISS EARNS COVETED MHRA QUALITY MARK
Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen.
The Cheshire-based team has a wealth of experience in supporting...
FortisNet: strength through collaboration
An interdisciplinary hub of expertise in regenerative medicine, orthopaedics, prosthetics and assistive technologies.
The musculoskeletal challenges described above form part of a wider landscape, where diabetic amputations have increased to 7,000 per year in the...
AI-powered simulations pair drugs with cancer patients
Finding solutions to complex diseases is top of the agenda for a collaboration between a leading UK innovation engine and a Budapest-based biotech firm.
Cancer Research Horizons is part of Cancer Research UK, the world’s...
Cell therapy manufacturing –making the future now
There is no mistaking the sure but steady revolution happening in cell therapy. With the long-held promise now rewarded with greater funding, investment and belief, the change in gear has been dizzying.
However, this is...
Synthetic mouse embryo models created from stem cells
An egg meets a sperm -- the necessary first step for life and a common first step in embryonic development research. But now researchers have grown synthetic embryo models of mice outside the womb...
Taking a global view
Work being done by Romanian and Ukranian scientists in the Danube Delta is helping to drive a research programme that could have global ramifications.
Findings by the Danube Delta Research Institute show that algae bloom...
The Aisa opportunity
Few international markets offer such huge opportunities for UK companies as the rapidly expanding health sector in China.
Now, the British Government is stepping up its drive to promote stronger links between the healthcare sectors...
An insight into the Cambridge economy – what lies ahead for Silicon Fen?
Dr Andy Cosh & Dr Giorgio Caselli - Centre for Business Research & University of Cambridge
These are rather frantic days for the UK, since several outcomes remain possible following the Brexit referendum in June 2016.
While the government...
Could your accountant have made a mistake with your Research and Development Tax Relief...
How would you know? What can you do about it? You could start by speaking with a specialist and even better someone who’s worked in a Top 5 CRO preparing claims for 6 years!
Now...
The power of ideas
Information lies at the heart of everything we do. We are surrounded by information technology and it allows us to look at life with different eyes.
In fact, the development of information, could, it be...
New ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
An extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification.
Pluripotent stem cell technology provider for drug discovery, Axol Bioscience Ltd (Axol), has signed an exclusive agreement...
Unravelling the DNA dilemma: A new chapter in rare disease research
‘Hope is not lost’ for the 50 per cent of people with undiagnosed rare diseases, says UK genomics expert Neil Ward, of PacBio. New technologies can provide more accurate, in-depth data on the genome,...
HEART DISEASE RESEARCHERS SET TO WORK WITH THE NOBEL PRIZE-WINNING GENETIC SCISSORS
By Dr Leanne Grech, Research Engagement Officer at the British Heart Foundation
We can all agree that 2020 has been a difficult year, but a silver lining was two women winning the Nobel Prize in Chemistry...
Bioscience companies find The North East Technology Park in County Durham the perfect place...
The North-East Technology Park, or NETPark, provides science, technology and engineering companies with the type of world-class laboratory, clean room and office space that can take businesses from a small start-up to a global AIM listed...
Urban development is attracting leading scientists and ambitious companies to the north
Newcastle Helix is the UK’s biggest urban development of its kind outside of London and has entered its next phase of development.
The £350m flagship project, brings together a community of academics, industry leaders, businesses...